Interstitial lung disease and surfactant dysfunction [65 genes]

Interstitial Lung Diseases (ILD) comprehend a heterogeneous group of diseases that are characterized by presenting different degrees of inflammation and fibrosis in lung tissue, usually irreversible and progressive. The newborn and child forms have different characteristics than those observed in adults, both in their clinical presentation as well as in their prognosis. In some of these entities a genetic origin was identified. Defects in various genes have been related with the development of these diseases, especially the ones related with surfactant metabolism and those related with DNA repair mechanisms.

Request study Informed consent
Steps to follow
Steps to follow
Click here to see the Guidelines for the collection and transport of biological samples

1) Download & fill out

Please cover as many fields as possible in both documents

2) Sample collection

See sample types in the guidelines

3) Pack the sample

Please pack the sample in a way to prevent leakage

4) Send the sample & the request

Please schedule the delivery for Monday–Friday: 8am – 5pm

5) Result: the report

Via: e-mail and/or through the customer portal

Ask for information
Solicita información de

Interstitial lung disease and surfactant dysfunction

"*" indicates required fields

This field is for validation purposes and should be left unchanged.
Consentimiento*
Technique: Exome

Turnaround time (TAT): 25 days

Ref. S-202008283

Updated (dd/mm/yy): 08/10/2025

Interstitial lung disease and surfactant dysfunction: View panel

The panel covers the genetic study of interstitial lung disease from a global perspective. We have included genes related with the most frequent entities, due to alterations in the synthesis and processing of the surfactant, and to the dysfunction of telomerase activity, along with other genes related with less frequent diseases that can present complex genotypes, on occasions associated with pulmonary fibrosis.

  • ABCA3
  • ACD
  • AP3B1
  • ASAH1
  • ATP11A
  • BLOC1S3
  • BLOC1S6
  • CASR
  • COPA
  • CSF2RA
  • CSF2RB
  • CTC1
  • DKC1
  • DPP9
  • DSP
  • DTNBP1
  • FAM111B
  • FAM13A
  • FARSA
  • FARSB
  • FLCN
  • FLNA
  • FOXF1
  • GBA1
  • GNA11
  • GRHL2
  • HPS1
  • HPS3
  • HPS4
  • HPS5
  • HPS6
  • ITGA3
  • MARS1
  • MUC5B
  • NAF1
  • NF1
  • NHP2
  • NKX2-1
  • NOP10
  • NPC1
  • NPC2
  • PARN
  • POT1
  • RNF168
  • RPA1
  • RTEL1
  • SERPINA1
  • SFTPA1
  • SFTPA2
  • SFTPB
  • SFTPC
  • SLC34A2
  • SLC7A7
  • SMPD1
  • STAT3
  • STING1
  • STN1
  • TBX4
  • TERT
  • TINF2
  • TSC1
  • TSC2
  • USB1
  • WRAP53
  • ZCCHC8

Priority Genes : Genes where there is sufficient evidence (clinical and functional) to consider them associated with the disease; they are included in the clinical practice guidelines.
Secondary Genes: Genes related to the disease, but with a lower level of evidence or that constitute sporadic cases.
* Candidate Genes: Not enough evidence in humans, but potentially associated with the disease.

References

  1. R. Sousa, P. Caetano Mota, N. Melo, H.N. Bastos, E. Padrão, J.M. Pereira, R. Cunha, C. Souto Moura, S. Guimarães, A. Morais. Heterozygous TERT gene mutation associated with familial idiopathic pulmonary fibrosis. Respiratory Medicine Case Reports 26 (2019) 118–122.
  2. lave´ Petrovski, et al. An Exome Sequencing Study to Assess the Role of Rare Genetic Variation in Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine, Volume 196, Number 1 | July 1 2017.
  3. Newton CA, Molyneaux PL and Oldham JM (2018) Clinical Genetics in Interstitial Lung Disease. Front. Med. 5:116. Sarah G. Chu, MD1 Souheil El-Chemaly, MD, MPH1 Ivan O. Rosas, MD1.Genetics and Idiopathic Interstitial Pneumonias. Semin Respir Crit Care Med 2016;37:321–330
  4. Christin S. Kuo, MD1 and Lisa R. Young,Interstitial lung disease in children. Curr Opin Pediatr. 2014 June; 26(3): 320–327
  5. Lawrence M. Nogee Interstitial lung disease in newborns. Semin Fetal Neonatal Med. 2017 August; 22(4): 227–233

Basic information about cookies

Welcome to the basic information about cookies on the website under the responsibility of the entity:

HEALTH IN CODE SL

A cookie is a small information file that is stored in your computer, smartphone or tablet every time you visit our website. Some cookies are ours (we will call them our own cookies) and others belong to external companies that provide services for our website.

Cookies can be of various types: technical cookies are necessary for our website to function; they do not require your permission and are the only ones we have enabled by default.

The other cookies are used to improve our website, to personalise it based on your preferences, or to be able to show you advertising tailored to your searches, preferences, and personal interests. You can accept all these cookies by clicking on the ACCEPT button or REFUSE button below.

For more information, please consult the COOKIES POLICY on our website.